Nelson Moss, Neurosurgeon at Neurosurgery at Memorial Sloan Kettering, posted on X about recent paper by Emanuela Ferraro et al., titled “Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System Disease” published on JAMA Network.
Authors: Emanuela Ferraro, Anne S. Reiner, Rabih Bou Nassif, Umberto Tosi, Samantha Brown, Sabrina Zeller, Chau T. Dang, Andrew D. Seidman, Nelson S. Moss
“CNS metastases=increasingly the main challenge in HER2+ breast cancer. Here we show that fully 55% of patients with such spread suffer CNS-related mortality; even more so in the growing (+longer-surviving) population with CNS-only disease.”